The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
Gastric acid is believed to be an important etiological factor in the pathogenesis of Barrett's esophagus. Pulsatile acid exposure increases cell proliferation in ex vivo Barrrett's tissue and normalization of esophageal pH reverses this. Proton pump inhibitors (PPIs) are the mainstay of t...
Autori principali: | Leedham, S, Jankowski, J |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
2007
|
Documenti analoghi
Documenti analoghi
-
Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
di: Omran eAlsalahi, et al.
Pubblicazione: (2015-01-01) -
Barrett’s Esophagus: Is It All That Bad?
di: GNJ Tytgat
Pubblicazione: (1999-01-01) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
di: Harry Snady
Pubblicazione: (2023-12-01) -
Mapping clonality in individual glands in human Barrett's esophagus
di: Leedham, S, et al.
Pubblicazione: (2007) -
Gingers and Their Purified Components as Cancer Chemopreventative Agents
di: John F. Lechner, et al.
Pubblicazione: (2019-08-01)